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Abstract
Interferon Regulatory Factor 1 (IRF-1) is a member of the IRF family of transcription factors, which have key and diverse roles
in the gene-regulatory networks of the immune system. IRF-1 has been described as a critical mediator of IFN-gamma
signalling and as the major player in driving TH1 type responses. It is therefore likely to be crucial in both innate and
adaptive responses against intracellular pathogens such as Plasmodium falciparum. Polymorphisms at the human IRF1 locus
have been previously found to be associated with the ability to control P. falciparum infection in populations naturally
exposed to malaria. In order to test whether genetic variation at the IRF1 locus also affects the risk of developing severe
malaria, we performed a family-based test of association for 18 Single Nucleotide Polymorphisms (SNPs) across the gene in
three African populations, using genotype data from 961 trios consisting of one affected child and his/her two parents (555
from The Gambia, 204 from Kenya and 202 from Malawi). No significant association with severe malaria or severe malaria
subphenotypes (cerebral malaria and severe malaria anaemia) was observed for any of the SNPs/haplotypes tested in any of
the study populations. Our results offer no evidence that the molecular pathways regulated by the transcription factor IRF-1
are involved in the immune-based pathogenesis of severe malaria.
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Introduction
Severe malaria is a life-threatening disease that kills over a
million individuals every year, with 90% of the deaths occurring in
Sub-Sahara African children below the age of five [1]. People
living in an endemic area often become infected with Plasmodium
falciparum malaria during childhood, but a small proportion of
children experience severe complications, the clinical outcome
depending on many factors, including the genetic make-up of the
human host. Malaria is recognised as a very strong selective force
in the recent evolutionary history of the human genome [2] and
therefore is a candidate of great interest for genetic association
analysis. Association studies can inform us on mechanisms of
protective immunity against malaria at every stage of infection, the
understanding of which is crucial for the development of effective
vaccines.
Members of the Interferon Regulatory Factor (IRF) family of
transcription factors have key and diverse roles in the gene-
regulatory networks of the immune system [3,4,5]. In particular
IRF-1 has been described as a critical mediator of IFN-gamma
signalling and as the major player in driving TH1 type responses
[3]. It is therefore likely to be crucial in both innate and adaptive
responses against intracellular pathogens such as P. falciparum.
In two recent complementary association studies conducted in
rural communities and malaria patients of Burkina Faso, we found
that IRF1 polymorphisms were associated with the ability to
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4206control P. falciparum infection: in adult asymptomatic individuals
living in rural villages IRF-1 alleles were associated with a higher
prevalence of P. falciparum infection; the same alleles were
associated with a higher parasite density in children with
uncomplicated and severe malaria [6]. However, our work did
not provide conclusive evidence for a role of this locus contributing
to or providing protection from the severe manifestations of
malaria disease [6], as may be found for a well known genetic
factor such as haemoglobin S (HbS) [7].
In order to investigate whether genetic variation at the IRF1
locus contributes to a child’s risk of developing severe malaria, we
conducted a large multi-centre association study. As human
populations in Africa show a great genetic diversity [8] population
structure must be taken into account when conducting population
based genetic association studies since it might lead to false positive
results [9]. To avoid this drawback we applied the complementary
Transmission Disequilibrium Test (TDT) approach [10]. Geno-
type data were collected from family trios consisting of one
affected child and his/her two parents, and the genotype
distribution observed in the severe malaria cases was compared
to its expected distribution derived on Mendel’s law of segregation.
A comparison of such family-based association methods versus
case-control approaches has been carried out using the well-
established association of the sickle cell trait with protection
against severe malaria. The two methods were found to have
similar power and to give similar estimates of the level of
protection [7]. Epidemiological studies have suggested that
features of severe malaria, with regards to both age-incidence
profiles and clinical spectrum, vary with levels of P. falciparum
transmission intensity [11]. We therefore conducted our associa-
tion analysis in trios from three sub-Saharan African countries
covering a range of malaria ecologies, The Gambia, Kenya and
Malawi.
Here we assess the role of IRF1 genetic variation in severe
malaria, and by considering multiple populations, we able to
investigate regional differences, whilst standardizing phenotype
definition and study design.
Results
We have genotyped 18 Single Nucleotide Polymorphisms
(SNPs) in the IRF1 genetic region (Figure 1) in 961 nuclear trios
comprising one child affected by severe malaria and his/her two
parents. Severe malaria patient samples were collected as part of
ongoing epidemiological studies at the Royal Victoria Hospital,
Banjul, The Gambia (555 trios); the Queen Elizabeth Central
Hospital, Blantyre, Malawi (202 trios); and Kilifi District Hospital,
Kilifi, Kenya (204 trios). The family trios were assessed for
pedigree misspecification using a panel of 48 additional markers
spread across the genome and the Nucl3ar software package [12].
The allele frequencies calculated among the trio founders
(Table 1) differ for many markers between The Gambia and either
Kenya or Malawi (significant difference for 14 and 12 SNPs
respectively), while they show a greater similarity between the two
East-African countries (significant difference for 3 SNPs only), as
we could expect on the basis of the geographical distribution and
history of the three populations.
The power of a TDT analysis to detect transmission distortion is
a function of the number of heterozygous parents in the sample
and the level of distortion at the locus [13]. Trios in which at least
one parent is heterozygous are informative in TDT analysis, and
therefore the heterozygosity of a locus can be used as a measure of
its information content in family-based association analysis. The
observed heterozygosity (H) in the study populations is relatively
high: The Gambia, HG=40.8%; Kenya, HK=38.7%; Malawi,
HM=38.0%. For comparison, in the HapMap populations
Yoruba (Ibadan, Nigeria) and CEPH (Utah residents with ancestry
from northern and western Europe) the heterozygosity of the IRF1
gene is the highest among the Th2 cluster (HY=38% and
HC=45%) while the heterozygosity of the neighbouring IL5 gene
Figure 1. The IRF1 locus and Single Nucleotide Polymorphisms (SNPs) tested for association with severe malaria in child-parental
trios. From top to bottom, the figure shows: human chromosome 5 with its G-banding patterns (black, grey and black bands) where the location of
the 5q31.1 band is indicated; genes contained within a 642 kb segment of the 5q31.1 band known as the ‘‘Th2 cytokine cluster’’; IRF1 gene region,
where the arrow indicates the direction of transcription, horizontal lines indicate intergenic regions, white boxes indicate 59 and 39 un-transcribed
regions (UTR), black boxes indicate exons and diagonal lines indicate introns; SNPs that were tested for severe malaria in our study populations and
their location with respect to the IRF1 gene region. Coordinates quoted (Mb) are based on Ensembl release 40.
doi:10.1371/journal.pone.0004206.g001
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(HapMap data release 3.1).
We conducted single marker and haplotype TDT association
analysis using a custom script implemented in R statistical software
and based on Transmit [14], and the equivalent FBAT approach
[15] for comparison of the results. Considering the differences in
allele frequencies observed, along with possible differences in
clinical spectrum, we conducted the association analysis separately
for each of the study populations. When a similar trend was
observed in each population, we would pool the data adjusting for
study region to increase the power.
The application of the single locus TDT to the 18 IRF1 SNPs
revealed no evidence of association (all P-values.0.05) across all
populations, neither with severe malaria or with the sub-
phenotypes of cerebral malaria (CM) and severe malaria anaemia
(SA) under any of the models tested (additive, dominant, recessive
and heterozygous advantage). The results for the test of association
with severe malaria under the additive model are shown in
Table 2. There was no evidence of heterogeneity or differences in
the allelic odds ratios between the CM and SA phenotypes for
each SNP (all P-values.0.05), supporting the interpretation above
that there were no strong SNP effects being masked by sub-clinical
phenotype.
In comparison, the HbS allele shows, as expected, a very strong
protective effect against severe malaria, with a reduction in risk of
81% and 87% in the Gambian (P=6610
219) and Kenyan
(P=9610
25) populations, respectively. The effect of the HbS
allele could not be tested in the trios from Malawi, due to its low
allele frequency in this population and therefore the number of
informative trios is not sufficient to compute the statistic.
Linkage Disequilibrium (LD) analysis was performed using the
HAPLOVIEW application [16] and revealed a similar haplotype
architecture in the three populations (Figure 2). Two blocks of high
LD have been identified- the first corresponding to the
downstream and coding region (SNPs rs7719499 to rs2070721;
average r2: Gambia=0.75, Kenya=0.72, Malawi=0.68) of the
gene, the second to the proximal upstream region (,5 kb from the
first exon, SNPs rs2706384 to rs2549002; average r2: Gam-
bia=0.70, Kenya=0.63, Malawi=0.56)–while very low levels of
LD were observed in the intergenic upstream region (.5 kb from
the first exon, SNPs rs736801 to rs2706391; average r2:
Gambia=0.08, Kenya=0.07, Malawi=0.05). These results are
consistent with previous findings in two other West-African
populations from Burkina Faso [6].
We tested the common haplotypes (frequency higher than 5%)
within each LD block for association with severe malaria
phenotypes. Similarly to the single locus TDT, no significant
association was observed (all P-values.0.05) in any of the study
populations. Table 3 shows the results for the test of association
with severe malaria.
Discussion
Rodent malaria studies have shown that IFN-gamma is a key
inducer of the immune effector mechanisms that are responsible
for the control of both pre-erythrocytic and blood-stage malaria
Table 1. Minor allele frequency of HBB and IRF1 Single Nucleotide Polymorphisms (SNPs) in trio parents from The Gambia, Kenya
and Malawi.
SNP Chr coord Location Alleles The Gambia Kenya Malawi MAF comparison (P-values)
MAF StE MAF StE MAF StE G vs K G vs M K vs M
HbS (rs334) 11:5204808 exonic T (A) 0.045 0.006 0.050 0.011 0.004 0.003 0.631 9E-08 3E-08
rs7719499 5:131841990 39 down G (C) 0.502 0.015 0.394 0.024 0.395 0.025 2E-07 3E-07 0.992
rs10065633 5:131844615 intronic T (C) 0.500 0.015 0.394 0.024 0.397 0.025 3E-07 1E-06 0.943
rs2070729 5:131847820 intronic C (A) 0.385 0.015 0.281 0.022 0.216 0.021 2E-07 1E-17 0.003
rs2070727 5:131848174 intronic C (A) 0.502 0.015 0.396 0.024 0.395 0.025 3E-07 3E-07 0.992
rs2070726 5:131849637 intronic C (A) 0.504 0.015 0.394 0.024 0.393 0.025 1E-07 1E-07 0.992
rs2070724 5:131849971 intronic G (A) 0.485 0.015 0.396 0.024 0.395 0.025 2E-05 2E-05 0.992
rs10213701 5:131851963 intronic T (A) 0.364 0.015 0.454 0.025 0.476 0.026 1E-05 8E-08 0.415
rs2070722 5:131852385 intronic T (G) 0.503 0.015 0.393 0.024 0.395 0.025 1E-07 3E-07 0.976
rs2070721 5:131853741 intronic A (C) 0.388 0.015 0.279 0.024 0.208 0.021 2E-07 2E-19 0.002
rs2706384 5:131854779 59 up A (C) 0.404 0.015 0.358 0.025 0.373 0.024 0.029 1E-01 0.576
rs2549005 5:131855090 59 up G (A) 0.490 0.015 0.483 0.025 0.469 0.026 0.771 3E-01 0.620
rs41525648 5:131855674 59 up C (T) 0.280 0.014 0.238 0.021 0.170 0.019 0.024 1E-09 0.001
rs2549004 5:131855724 59 up C (G) 0.404 0.015 0.366 0.024 0.375 0.024 0.067 2E-01 0.749
rs2549002 5:131857477 59 up T (G) 0.380 0.015 0.337 0.024 0.350 0.024 0.034 1E-01 0.620
rs736801 5:131861498 intergenic T (C) 0.054 0.007 0.013 0.006 0.006 0.004 5E-06 2E-08 0.253
rs4705952 5:131867517 intergenic A (G) 0.354 0.015 0.373 0.024 0.381 0.024 0.358 2E-01 0.781
rs2706390 5:131870179 intergenic A (C) 0.201 0.012 0.118 0.016 0.094 0.015 2E-07 2E-11 0.141
rs2706391 5:131871205 intergenic C (T) 0.051 0.007 0.041 0.010 0.053 0.011 0.303 9E-01 0.315
The table shows the SNPs that have been genotyped in the affected child parental trio studies and their frequency in trio parents from The Gambia, Kenya and Malawi.
These are not unbiased estimates of the population frequencies. Chr coord is the SNP chromosome coordinate (chromosome: base pair) based on Ensemble release 40.
Location: location of the SNP with respect to the HBB or IRF1 locus. Alleles: minor and major alleles (major allele is shown in brackets). MAF: Minor Allele Frequency in
pedigree parents (The Gambia, N=1100; Kenya, N=408; Malawi, N=404). StE: Standard Error of the MAF. MAF comparison: P-values of Yates corrected x
2 Test for
comparison of MAF between populations; a P-value,0.05 is considered statistically significant. G: The Gambia. K: Kenya. M: Malawi.
doi:10.1371/journal.pone.0004206.t001
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Malawian child-parental trios.
SNP Inform The Gambia Inform Kenya Inform Malawi
OR LCL UCL TDT P OR LCL UCL TDT P OR LCL UCL TDT P
HbS (rs334) 170 0.19 0.13 0.28 6E10
219 26 0.13 0.04 0.43 9E10
25 3 --- -
rs7719499 513 0.98 0.82 1.17 0.83 169 0.99 0.73 1.34 0.94 195 0.89 0.67 1.18 0.43
rs10065633 499 0.96 0.80 1.14 0.62 168 1.00 0.74 1.35 1.00 185 0.91 0.68 1.21 0.51
rs2070729 496 1.00 0.84 1.19 1.00 154 1.00 0.73 1.37 1.00 131 0.77 0.55 1.09 0.14
rs2070727 504 0.93 0.78 1.11 0.42 169 0.97 0.71 1.30 0.82 194 0.94 0.71 1.25 0.67
rs2070726 494 0.96 0.81 1.15 0.65 163 1.04 0.76 1.41 0.81 178 0.98 0.73 1.31 0.88
rs2070724 460 0.97 0.81 1.17 0.78 167 1.06 0.78 1.44 0.70 193 1.05 0.79 1.40 0.72
rs10213701 452 0.94 0.78 1.13 0.51 172 1.02 0.76 1.38 0.88 156 0.88 0.64 1.20 0.42
rs2070722 493 0.95 0.80 1.13 0.56 161 1.01 0.74 1.38 0.94 183 0.89 0.66 1.19 0.42
rs2070721 468 1.00 0.83 1.20 1.00 103 1.24 0.84 1.83 0.28 111 0.79 0.54 1.15 0.22
rs2706384 489 0.97 0.81 1.16 0.75 131 0.87 0.62 1.23 0.43 178 0.89 0.67 1.20 0.45
rs2549005 484 1.03 0.86 1.23 0.79 156 0.93 0.68 1.27 0.63 150 0.97 0.71 1.34 0.87
rs41525648 412 0.98 0.81 1.19 0.84 138 1.00 0.72 1.40 1.00 114 0.84 0.58 1.21 0.35
rs2549004 490 0.98 0.82 1.16 0.79 166 0.93 0.69 1.26 0.64 187 0.97 0.73 1.29 0.83
rs2549002 483 0.96 0.80 1.14 0.62 166 0.95 0.70 1.29 0.76 180 0.96 0.71 1.28 0.77
rs736801 85 0.73 0.48 1.13 0.16 9 0.80 0.21 2.98 0.74 4 0.33 0.03 3.20 0.32
rs4705952 462 1.00 0.83 1.20 1.00 191 1.20 0.90 1.59 0.22 177 1.08 0.81 1.45 0.60
rs2706390 313 0.97 0.78 1.21 0.78 83 0.93 0.60 1.43 0.74 63 1.42 0.86 2.35 0.17
rs2706391 95 0.73 0.48 1.09 0.12 26 1.00 0.46 2.16 1.00 28 1.55 0.72 3.30 0.26
The table shows the SNPs tested in association analysis with severe malaria and results of the TDT in the three populations of affected child-parental trios. Inform is the
number of informative trios. OR: Odds Ratio comparing the risk of the minor vs major allele. LCL and UCL: Lower and Upper Confidence Limits of a 95% Confidence
Interval respectively. TDT P: P-value for the family-based test of association. P-values,0.05 are shown in bold.
doi:10.1371/journal.pone.0004206.t002
Figure 2. Linkage Disequilibrium (LD ) architecture of the IRF1 locus in The Gambia, Kenya and Malawi. Typed single nucleotide
polymorphisms (SNPs) are represented on the vertical axis and ordered by chromosome position as in Table 1. Diagonal lines in two directions link
each SNP to each of the other 17 SNPs. The LD (D
2) between each pair of markers is represented by diamonds of different colours (see legend). D
2 is a
simple measure of correlation between markers and is calculated as follows: (fAB fab2fAb faB)
2/(fA fa fB fb), where f stands for frequency, A and a denote
the alleles at the first marker, B and b denote the alleles at the second marker, Ab is the haplotype carrying the major allele for the first marker and
the minor allele for the second marker and so on. Blocks 1 and 2 are set of markers in high LD identified within the gene using the HAPLOVIEW
application [16].
doi:10.1371/journal.pone.0004206.g002
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studies conducted in human populations have shown that malaria
induced IFN-gamma production is associated with lower infection
rates and resistance to re-infection [18] and with reduced risk of
clinical malaria [19]. For these reasons IFN-gamma is considered
as a correlate of cellular immunity to malaria and thus used as a
marker for vaccines immunogenicity and efficacy [17]. On the
other hand, both in mice and humans, an excessive inflammatory
response with high systemic levels of IFN-gamma, TNF-alpha, IL-
6 and IL-1, has long been correlated with immune-based
pathogenesis of severe disease [reviewed in 20]. The tight
regulation of IFN-gamma production and signalling appears
therefore of great importance in determining susceptibility to
malaria.
We have previously investigated the role of the transcription
factor IRF-1, a critical effector molecule in IFN-gamma signalling,
in susceptibility to malaria by conducting genetic association
studies in Burkina Faso based on cross-sectional parasitological
surveys and case-control clinical studies. We have shown that IRF1
polymorphisms are associated with the control of P. falciparum
infection (parasite prevalence and density), both in healthy adult
subjects and in children with uncomplicated and severe malaria.
In those studies we did not find conclusive evidence for the
involvement of this locus in the severe manifestations of malaria
disease. Indeed, only a trend of association with small differential
risk of severe disease was suggested [6].
In the present study we investigated whether genetic variation at
the IRF1 locus affects susceptibility to severe malaria by
performing a family based association test in nuclear trios
consisting of an affected child and his/her two parents from The
Gambia, Kenya and Malawi. The trio design is robust to
population stratification. We did not observe any significant
associations between the SNPs or haplotypes analysed in severe
malaria in any of the three study populations.
There are various possible interpretations of these findings. The
effects of IRF1 polymorphisms on severe malaria may be too small
to be detected with this sample size, or may affect only a sub-
phenotype of severe malaria. It is likely that the genetic basis of
susceptibility to malaria is built upon many different protective
genes, each individually resulting in small effects [21]. This study
lacks power to detect a small effect [13]. For example, consider a
situation where we have 555 trios and wish to detect (assuming a
false positive rate of 5%) a multiplicative genotypic effect at a SNP
with minor allele frequency of 0.2. If the magnitude of the odds
ratio to detect is 1.5 (50% increased risk) we would have .90%
power. However, if we wish to detect an odds ratio of only 1.2
(20% increased risk), we would have only 42% power, and would
require ,1400 trios to achieve 80% power. These estimates also
assume that the SNP genotyped is in perfect linkage disequilibrium
(D
2=1) with the causal polymorphism. Overall, we find no
evidence that IRF1 is a strong determinant of susceptibility to
severe disease in our study populations.
When considering the exceptionally high diversity of the human
genome in African populations [8] we must also take into account
that different malaria-resistant alleles may have arisen in different
populations due to differences in selective pressure and demo-
graphic history. This is the case, for example, of HbC, whose
prevalence varies greatly between neighbouring countries and
even villages [22,23]. It is therefore possible that IRF1 functional
variants with an effect on malaria susceptibility/resistance exist in
the Fula and Mossi populations of Burkina Faso but not in the
study populations presented here. Moreover, we cannot rule out
that a different pattern of association could be observed in other
African populations as a consequence of a different genetic
background. Further disease-association studies across Africa and
including Burkina Faso will be needed to answer this question.
Finally, it might be possible that the association of IRF1
polymorphisms with the ability to control P. falciparum infection
and the lack of association with susceptibility to severe disease
actually reflect differences in the molecular mechanisms underly-
ing protective/pathological immune responses at different stages of
infection. The gene regulatory networks of the immune system
that are activated during malaria infection and that are responsible
for parasite killing may differ from those leading to an over-
reaction to the parasite that is harmful to the host, depending for
example on the molecular triggers from the parasite or on the
tissues involved. That this could be the case has been recently
suggested by a genome-wide linkage analysis of parasite density
and mild malaria in two Senegalese villages. Regions of linkage
showed little if any overlap with genes previously described to be
Table 3. Haplotype Transmission Disequilibrium Test (TDT) of association with severe malaria in Gambian, Kenyan and Malawian
child-parental trios.
Haplotypes The Gambia Kenya Malawi
Freq Inform OR LCL UCL TDT P Freq Inform OR LCL UCL TDT P Freq Inform OR LCL UCL TDT P
Block 1
GTCCCGATA 0.38 470 0.96 0.82 1.18 0.64 0.27 151.60 0.97 0.72 1.35 0.83 0.21 124.1 1.11 0.73 1.49 0.57
CCAAAATGC 0.36 438 1.09 0.86 1.25 0.35 0.45 186.80 0.98 0.75 1.32 0.90 0.48 179.2 1.13 0.79 1.41 0.43
CCAAAAAGC 0.14 213 0.84 0.71 1.21 0.20 0.16 110.80 1.06 0.71 1.49 0.74 0.13 85.9 0.82 0.60 1.40 0.36
GTACCGATC 0.11 208 1.06 0.78 1.35 0.67 0.11 79.70 1.03 0.65 1.57 0.89 0.18 99.8 0.84 0.63 1.38 0.40
Block 2
CATGG 0.51 498 1.00 0.84 1.19 0.96 0.52 183.60 0.90 0.72 1.28 0.50 0.52 181.4 1.01 0.75 1.34 0.95
AGCCT 0.28 409 1.03 0.84 1.23 0.74 0.24 136.90 1.01 0.72 1.40 0.97 0.17 117.5 1.18 0.75 1.54 0.38
AGTCT 0.10 185 1.09 0.78 1.38 0.58 0.09 68.80 1.28 0.69 1.79 0.31 0.16 98.4 0.81 0.61 1.35 0.29
CGTGG 0.09 147 0.91 0.69 1.33 0.57 0.11 83.00 1.08 0.67 1.59 0.73 0.10 66.2 0.86 0.58 1.52 0.55
The table shows the common haplotypes (frequency higher than 5%) within each LD block identified in the gene, their frequency and the results of family-based test of
association with severe malaria in the three populations of affected child-parental trios. Freq: frequency of the haplotype in trio parents. These are not unbiased
estimates of the population frequencies. OR: Odds Ratio comparing the risk of the untransmitted versus the transmitted haplotype. All other abbreviations as in Table 2.
doi:10.1371/journal.pone.0004206.t003
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genes involved in asthma and atopy related traits [24]. Further
insights could be gained by conducting fine mapping studies in
multiple populations of larger sample size, where both phenotypes,
parasite load and disease severity, could be inspected against the
same genetic background. However, the data so far available offer
no evidence that the molecular pathways regulated by the
transcription factor IRF-1 are involved in immune-based patho-
genesis of severe malaria.
Methods
Child-parental trios
Severe malaria patient samples were collected as part of
ongoing epidemiological studies at the Royal Victoria Hospital,
Banjul, The Gambia (555 trios); the Kilifi District Hospital, Kilifi,
Kenya (204 trios); and the Queen Elizabeth Central Hospital,
Blantyre, Malawi (202 trios). Nuclear family trios comprised one
affected child and his two parents.
The research protocols used in this study have obtained
approval from the relevant ethics committees: the United
Kingdom approval was given by the Oxfordshire Clinical
Research Ethics Committee (OxREC); the Gambian approval
was given by the Gambia Government/Medical Research Council
(MRC) Joint Ethics Committee; the Kenyan approval was given
by Kenya Medical Research Institute (KEMRI)/National Ethical
Review Committee; the Malawi approval was given by the Health
Sciences Research Committee and College of Medicine Research
Committee (COMRC).
All DNA samples were collected and genotyped following
informed consent from participants. Some of the samples for this
study were collected with written consent, others with verbal
consent. In all cases the advice of the local ethics committee about
the appropriate ways of recording consent in the local research
context was followed.
The family trios were assessed for pedigree misspecification
using a panel of 48 additional markers spread across the genome
and the Nucl3ar software package [12].
Severe malaria cases and phenotypes definition
All cases were children admitted to hospital with evidence of P.
falciparum on blood film and clinical features of severe malaria
[25,26]. We used a Blantyre coma score of #2 as a criterion of
cerebral malaria (CM), and haemoglobin ,5 g/dl or packed cell
volume ,15% as a criterion of severe malaria anaemia (SA). Some
individuals had both CM and SA. Of the severe malaria cases that
were not CM or SA by these criteria, most had lesser degrees of
coma (Blantyre coma score 3) or anaemia (Hb 5–6 g/dl), or other
complications such as respiratory distress.
The sub-clinical phenotype frequencies in the probands were: (i)
The Gambia (443 CM, 239 SA, 141 both CM/SA, 14 other), (ii)
Kenya (109 CM, 77 SA, 31 CM/SA, 49 other) and (iii) Malawi
(195 CM, 52 SA, 49 CM/SA, 4 other).
The median (range) ages of the Gambian, Kenyan and
Malawian cases expressed in months were 41 (0-156), 26 (0-121)
and 31.5 (2-156), respectively.
Markers selection, DNA samples preparation and
genotyping
Single Nucleotide Polymorphisms (SNPs) in the region 10 kb
upstream to 10 kb downstream of the IRF1 gene were identified
from public databases (dbSNP build 126, Ensemble release 40)
and the literature.
18 polymorphisms were selected on the basis of the following
criteria: validated status by frequency, haplotype tagging SNP
(htSNP) in the HapMap Yoruba population, overall coverage of
the locus with regular spread (density of 1 SNP every 2 Kb on
average), encompassing exonic, intronic, regulatory regions of the
gene. Database identifiers and location with respect to the IRF1
gene of the 18 SNPs are displayed in Figure 1 and listed in Table 1.
Genomic DNA samples underwent whole genome amplification
through either Primer Extension Pre-amplification (PEP) [27] or
Multiple Displacement Amplification (MDA) [28] before genotyping.
The genotypes for the selected polymorphisms were determined
through the SEQUENOM MassARRAY
TM System [29]. One
assay (rs839) did not pass quality filters following initial testing (call
rate,90% and evidence that the genotypes in the founders
deviated from Hardy-Weinberg equilibrium [30] (P,0.001). This
SNP has therefore been excluded from any further analysis.
Haplotypes and Linkage Disequilibrium architecture
Haplotypes have been constructed using family data and the
Stephens-Donnelly method [31]. Haplotypes blocks across the genes
have been defined using the HAPLOVIEW application [16], based
on the method originally described by Gabriel and colleagues [32].
LD metrics and graphs showing LD patterns have been
generated using the MARKER (http://www.gmap.net/perl/
marker/marker_entry) application. Typed single nucleotide poly-
morphisms (SNPs) are represented on the vertical axis and ordered
by chromosome position as in Figure 1. The linkage disequilib-
rium between each pair of markers is represented by diamonds of
different colours.
Statistical methods
Allele frequencies have been calculated among pedigree
founders and Hardy-Weinberg equilibrium has been tested, using
the dedicated software PEDSTATS [33]. These are not unbiased
estimates of the population frequencies. Allele distributions
between populations have been compared by Yates-corrected x
2
test. If contingency tables had less than 5 expected events per cell,
Fisher’s exact test was used.
Trio association analysis was performed using the transmission
disequilibrium test (TDT). This tests for family-based association
in the presence of genetic linkage between a SNP and severe
malaria [10], and is robust to the presence of population structure.
Single locus and haplotype versions of the TDT were implemented
using R statistical software based on Transmit [14]. The FBAT
application [15] (software available at http://biosun1.harvard.
edu/,fbat/fbat.htm) has been used for comparison of the results.
Haemoglobin genotyping was previously performed on all
samples included in the study [34] and association of HbS with
severe malaria has been used as positive control for the TDT results.
A P-value of 0.05 has been considered as the threshold for
statistical significance.
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